...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corporation symbol

I caution anyone reading too much into Zenith action as two companies keep getting mixed up. Globe & Mail mixed them up a couple of weeks ago and put Zenith Capital Corp. (our company) information on Zenith Capital Corporation (another unrelated company as far as I know listed as ZENI-P). Below is from a filing on SEDAR for the other company when they started trading in March. It is just a small capital pool company.

“March 6, 2020 – Vancouver, British Columbia - Zenith Capital Corporation (the “Corporation”) (TSX-V: ZENI.P), a capital pool company, is pleased to announce that it has successfully completed its initial public offering (the “Offering”) of 2,000,000 common shares (the “Shares”) for gross proceeds of $200,000 through its agent, Canaccord Genuity Corp. (the “Agent”). In connection with the Offering, the Corporation granted to the Agent non-transferable warrants to purchase up to 200,000 Shares at a price of $0.10 per Share, which may be exercised until March 6, 2022. The Agent also received a cash commission and an administration fee for its services in connection with the Offering. The net proceeds of the Offering will be used by the Corporation to identify and evaluate assets or businesses for acquisition with a view to completing a "Qualifying Transaction" under the Capital Pool Company program of the TSX Venture Exchange (the “Exchange”). The board of directors of the Corporation consists of Charalambos (Harry) Katevatis, Vivian Katsuris and Theo Sanidas. An aggregate of 400,000 stock options have also been granted to the directors and officers of the Corporation to acquire Shares of the Corporation at an exercise price of $0.10 per Share with an expiry date of March 6, 2025. The Shares were listed on the Exchange on March 6, 2020 and immediately halted pending closing of the Offering. The Shares are expected to commence trading on the Exchange on March 10, 2020 under the trading symbol “ZENI.P”. On behalf of the board of Zenith Capital Corporation Per: “Charalambos Katevatis” Charalambos Katevatis President, CEO, CFO, Corporate Secretary and Director

My iTrade account shows the same ZHCLF symbol and shows a cost in USD. What they show is only about ¾ of what my actual ACB is though. Your ACB should be 9.1% of what you paid for the RVX shares that got split if that is how you obtained the shares. I changed my cost to that 9.1% and then converted to USD and it is still higher by that amount. They are showing my cost at approximately what the other company has traded at since it started trading in March.

I think it would be wise to just stick to the information given by our ZCC as little as that is because that might be all there is.

Share
New Message
Please login to post a reply